Leucine-Rich alpha-2 Glycoprotein 1 (LRG1) (N-Term) Peptid
LRG1
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle LRG1 Produkte
- LRG1 (Leucine-Rich alpha-2 Glycoprotein 1 (LRG1))
- Protein Region
- N-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- GVTLSPKDCQ VFRSDHGSSI SCQPPAEIPG YLPADTVHLA VEFFNLTHLP
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-LRG1 Antibody(ARP52475_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- LRG1 (Leucine-Rich alpha-2 Glycoprotein 1 (LRG1))
- Hintergrund
-
The leucine-rich repeat (LRR) family of proteins, including LRG1, have been shown to be involved in protein-protein interaction, signal transduction, and cell adhesion and development. LRG1 is expressed during granulocyte differentiation (O'Donnell et al., 2002 [PubMed 12223515]).
Alias Symbols: HMFT1766, LRG
Protein Interaction Partner: FN1
Protein Size: 347 - Molekulargewicht
- 38 kDa
- Gen-ID
- 116844
- NCBI Accession
- NM_052972, NP_443204
- UniProt
- P02750
-
Sie sind hier:
